Envoy Medical, Inc. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Envoy Medical Corporation hired Robert Potashnick as Chief Accounting Officer and Vice President of Finance effective August 24, 2026, at a base salary of $315,000 per annum. Potashnick received 250,000 stock options at the closing trading price on the effective date, plus eligibility for a 15% target bonus in the first 12 months based on achievement of Board-determined milestones. The three-year employment agreement includes standard severance (6 months base salary for non-cause termination), change-of-control acceleration of unvested equity, and restrictive covenants (24-month non-solicitation of employees and customers post-termination).
Why this rating
Routine C-level hire. $315K salary + equity is normal executive compensation, immaterial relative to $12.7M market cap. No revenue, customer, or strategic impact disclosed.
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.